GHRP-2 (10 mg Vial)

Reconstitution and handling reference for GHRP-2 (10 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
GHRP-2 (10 mg Vial)

Synonyms/Alias: GHRP-2

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Reconstitution and handling reference for GHRP-2 (10 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → ~ 3.33 mg/mL concentration.

Typical daily range: 100–300 mcg once daily (gradual titration).

Easy measuring: At 3.33 mg/mL, 1 unit ≈ 33.3 mcg on a U‑100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [10]. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation [11]. Inject slowly; wait a few seconds before withdrawing the needle. A 5‑days‑on/2‑days‑off schedule may help maintain GH response sensitivity over long protocols [7]. Document daily dose and site rotation to maintain consistency.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Daily Dose (mcg): 100 mcg (0.1 mg) | Units (per injection) (mL): 3 units (0.03 mL)
Weeks 3–4
Daily Dose (mcg): 150 mcg (0.15 mg) | Units (per injection) (mL): 4.5 units (0.045 mL)
Weeks 5–8
Daily Dose (mcg): 200 mcg (0.2 mg) | Units (per injection) (mL): 6 units (0.06 mL)
Weeks 9–12 (optional)
Daily Dose (mcg): 250–300 mcg (0.25–0.3 mg) | Units (per injection) (mL): 7.5–9 units (0.075–0.09 mL)
Long-term Storage Conditions
Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (GHRP-2, 10 mg each): 8 weeks ≈ 1 vial (~9.1 mg used)

12 weeks ≈ 2 vials (~15.4 mg used)

16 weeks ≈ 3 vials (~22.4 mg used)

Insulin Syringes (U‑100, 30‑ or 50‑unit recommended for precision): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle

12 weeks (2 vials): 6 mL → 1 × 10 mL bottle

16 weeks (3 vials): 9 mL → 1 × 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100‑count boxes

12 weeks: 168 swabs → recommend 2 × 100‑count boxes

16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Sharps Container: 1‑quart container holds ~100 syringes; 2‑quart for 16‑week protocols.

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China